Actively Recruiting
Evaluating Safety and Immune Response of vYF Compared to Licensed Yellow Fever Vaccines in Children 9 Months to 5 Years Including Co-administration with MMR Vaccine
Led by Sanofi · Updated on 2026-10-14
2440
Participants Needed
15
Research Sites
170 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and immune response of an investigational yellow fever vaccine called vYF in young children aged 9 months to 5 years. This Phase III study compares vYF with two licensed yellow fever vaccines, Stamaril and YF-VAX, including when vYF is given alongside the measles, mumps, and rubella MMR vaccine in infants aged 11 to 15 months. The study aims to see if vYF can safely help the body develop protective antibodies against yellow fever. Participants will be randomized into groups by age to receive one dose of either vYF, Stamaril, or YF-VAX vaccine. A special group of infants aged 11 to 15 months will receive vYF together with the MMR vaccine in one visit. A subset of children aged 9 to 24 months will be invited to receive a booster dose of the yellow fever vaccine three years after the initial vaccination. The booster is not offered to the group receiving the combined vYF and MMR vaccine. Participants will be involved for about three years, with some in the booster group followed for an additional six months. The study includes multiple blood tests to measure immune response at several time points, starting from the day of vaccination and continuing annually up to three years. Safety is monitored closely through reports of side effects and laboratory tests. The main outcome is the percentage of participants developing antibodies against yellow fever 28 days after vaccination.
CONDITIONS
Brief Title
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Research Team
T
Trial Transparency email recommended (Toll free for US & Canada)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here